Business ❯ Finance ❯ Investments ❯ Stocks

Pharmaceutical Stocks

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

The move from injectables to daily pills is broadening patient access and forcing drugmakers and suppliers to race for approvals, capacity and commercial deals.

12 ARTICLES

2mo ago

Eli Lilly Rides Breakthrough Retatrutide Data and $4 Billion Vaccine Push to Record Highs

6 ARTICLES

2mo ago

ImmunityBio Rallies as Anktiva Sales Surge 700% and Registrational Trial Passes 85% Enrollment

4 ARTICLES

7mo ago

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

16 ARTICLES

8mo ago

Eli Lilly Briefly Hits $1 Trillion as GLP-1 Boom Spurs Fresh Analyst Targets

5 ARTICLES

10mo ago

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

Pharmaceutical Stocks

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

Eli Lilly Rides Breakthrough Retatrutide Data and $4 Billion Vaccine Push to Record Highs

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

Analysts Lift Eli Lilly Targets After Blowout Quarter and Foundayo Debut

Biogen to Buy Apellis for $5.6 Billion in Cash, Adding Syfovre and Empaveli

Summit Therapeutics Shares Rally as Ivonescimab Trials Near Q2 Readout

Analysts Reinforce Eli Lilly’s Bull Case on Strong 2026 Guide, GLP-1 Momentum

ImmunityBio Rallies as Anktiva Sales Surge 700% and Registrational Trial Passes 85% Enrollment

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

Eli Lilly Briefly Hits $1 Trillion as GLP-1 Boom Spurs Fresh Analyst Targets

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target